<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-148895" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Lecithin-Cholesterol Acyltransferase Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Carty</surname>
            <given-names>Jordan R.</given-names>
          </name>
          <aff>University of the West Indies Medical School</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anastasopoulou</surname>
            <given-names>Catherine</given-names>
          </name>
          <aff>Jefferson Einstein Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jordan Carty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Catherine Anastasopoulou declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-148895.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Lecithin cholesterol acyltransferase (LCAT) deficiency is a rare inherited syndrome characterized by the partial or complete absence of LCAT enzyme activity.<xref ref-type="bibr" rid="article-148895.r1">[1]</xref>&#x000a0;LCAT is an enzyme attached to both high-density&#x000a0;lipoprotein (HDL) and low-density lipoprotein (LDL) particles and is responsible for the esterification of cholesterol, a crucial step in the metabolism of HDL particles. Deficiency of LCAT leads to impaired HDL metabolism, resulting in abnormal lipid profiles and predisposing to complications.<xref ref-type="bibr" rid="article-148895.r2">[2]</xref>&#x000a0;There are&#x000a0;2 clinical variants of the disease. The first is familial LCAT deficiency that involves a complete deficiency of the enzyme. The second is Fish-eye disease characterized by a partial deficiency of the enzyme.</p>
      </sec>
      <sec id="article-148895.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>LCAT deficiency, an autosomal recessive disease, results from mutations in the LCAT gene located on chromosome 16 (16q22). The mutations result in either the complete&#x000a0;deficiency of the functional LCAT enzyme (familial LCAT deficiency) or a partial reduction in the enzyme activity (Fish-eye disease).<xref ref-type="bibr" rid="article-148895.r3">[3]</xref></p>
      </sec>
      <sec id="article-148895.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>LCAT deficiency is an extremely rare disorder, with only a few hundred cases reported worldwide. The exact prevalence of LCAT deficiency is unknown, but it is estimated to occur in approximately 1 in 1,000,000 individuals.<xref ref-type="bibr" rid="article-148895.r4">[4]</xref>&#x000a0;A detailed analysis of sex predilection and ethnicity is difficult, given the rarity of the condition.</p>
      </sec>
      <sec id="article-148895.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Lipoproteins represent spherical complexes comprised of lipids encased by proteins and enveloped by a phospholipid monolayer. Metabolizing dietary triglycerides begins within the stomach and duodenum, where they are transformed into monoglycerides, free fatty acids, and unbound cholesterol. Bile acid micelles then move the molecules to the intestinal villi to be assimilated by enterocytes, reconverted into triglycerides, and repackaged as chylomicrons.<xref ref-type="bibr" rid="article-148895.r5">[5]</xref></p>
        <p>These chylomicrons encounter metabolism through lipoprotein lipase, leading to the liberation of free fatty acids and monoglycerides. The remnants of chylomicrons, enriched with cholesterol, undertake transportation to the liver, where they undergo further metabolic processing to give rise to very low-density&#x000a0;lipoprotein (VLDL). This VLDL is further degraded into lipoproteins abundant in cholesterol&#x02014;intermediate density lipoprotein (IDL) and LDL.<xref ref-type="bibr" rid="article-148895.r6">[6]</xref></p>
        <p>In contrast, HDL, devoid of cholesterol, emerges as particles synthesized within enterocytes and the liver. HDL assumes the role of acquiring cholesterol from peripheral tissues and other lipoproteins, subsequently facilitating its transportation to the liver and other bodily tissues. The process is mediated&#x000a0;through the cholesterol ester transfer protein. Essential to the maturation and remodeling of HDL, the LCAT enzyme catalyzes the conversion of free cholesterol into cholesteryl esters within the HDL particles.<xref ref-type="bibr" rid="article-148895.r7">[7]</xref></p>
        <p>In cases of LCAT deficiency, either impaired or absent LCAT activity, a consequential accumulation of free cholesterol within HDL particles transpires. As a result, the formation of cholesteryl esters becomes compromised, leading to the buildup of abnormal lipids, particularly unesterified cholesterol and phospholipids. This altered lipid composition significantly compromises the structural integrity and functional capacity of HDL particles.<xref ref-type="bibr" rid="article-148895.r8">[8]</xref></p>
      </sec>
      <sec id="article-148895.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Documented&#x000a0;studies reveal histological findings linked to LCAT deficiency. These findings include foam cells and sea-blue histiocytes observed in biopsies taken from bone marrow, spleen, and kidneys.<xref ref-type="bibr" rid="article-148895.r9">[9]</xref><xref ref-type="bibr" rid="article-148895.r10">[10]</xref></p>
      </sec>
      <sec id="article-148895.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The clinical presentation of the disease varies depending on the type of deficiency. Patients with familial LCAT deficiency exhibit a range of signs and symptoms, including corneal opacities, renal insufficiency, hemolytic anemia, atherosclerosis-related symptoms, xanthelasmata, hepatomegaly, splenomegaly, and lymphadenopathy.<xref ref-type="bibr" rid="article-148895.r11">[11]</xref>&#x000a0;The corneal opacities are minute, grayish dots dispersed across the corneal stroma, especially prominent at the corneal periphery.</p>
        <p>In contrast, individuals with Fish-eye disease experience milder symptoms, often presenting with impaired vision due to corneal opacities. While this variant rarely showcases other symptoms seen in familial LCAT deficiency, splenomegaly, hepatomegaly, and lymphadenopathy may arise.<xref ref-type="bibr" rid="article-148895.r12">[12]</xref>&#x000a0;Notably, the Fish-eye variant often exhibits a more severe degree of corneal opacification.</p>
      </sec>
      <sec id="article-148895.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Besides clinical observations and maintaining a high index of suspicion,&#x000a0;laboratory findings remain pivotal in&#x000a0;determining the diagnosis.</p>
        <p>Individuals with complete LCAT deficiency often exhibit normochromic normocytic anemia, characterized by target cells and anisopoikilocytosis. Signs of hemolysis may manifest as heightened lactate dehydrogenase levels, indirect and direct hyperbilirubinemia, and diminished haptoglobin levels. Evaluating renal function is essential as patients are prone to progressive renal insufficiency with elevated blood urea nitrogen, plasma creatinine, proteinuria, and reduced creatinine clearance.<xref ref-type="bibr" rid="article-148895.r13">[13]</xref></p>
        <p>The lipid panel is paramount. It highlights lipid abnormalities, such as markedly low HDL-C levels (usually &#x0003c;10 mg/dL), elevated VLDL and triglyceride levels, heightened plasma unesterified cholesterol concentrations, and reduced plasma cholesterol ester concentrations. The plasma LCAT enzyme activity measurement is typically indicative, with absence being the norm. The plasma fails to esterify radioactive cholesterol in exogenous apolipoprotein A-I containing liposomes. Currently,&#x000a0;no test is available to assess the esterification of radioactive cholesterol within endogenous lipoproteins.</p>
        <p>In contrast, Fish-eye disease exhibits distinct laboratory findings. It is characterized by low HDL-C levels (approximately 10% of normal), elevated VLDL and triglyceride levels, heightened unesterified cholesterol in HDL, and reduced cholesterol ester in HDL while remaining within the normal range for LDL and VLDL.<xref ref-type="bibr" rid="article-148895.r14">[14]</xref>&#x000a0;The rate of plasma cholesterol esterification is normal, although there is an incapacity of the plasma to esterify radioactive cholesterol in exogenous lipoproteins or HDL, except for LDL.&#x000a0;There are no hematological or renal abnormalities</p>
        <p>Routine measurement of LCAT activity is&#x000a0;unavailable in most laboratories, necessitating referral to a specialized center for a definitive diagnosis.</p>
      </sec>
      <sec id="article-148895.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is no definitive treatment available for LCAT deficiency. Instead, the primary focus of management revolves around addressing its complications. This involves implementing dietary modifications, exercise, lipid-lowering therapies, and antihypertensive medications, particularly&#x000a0;angiotensin-converting inhibitors (ACE-Is) or angiotensin receptor blockers (ARBs). These measures constitute the cornerstone of treatment and have demonstrated efficacy in slowing disease progression. Additionally, corticosteroid therapy has been proposed as a potentially advantageous option.<xref ref-type="bibr" rid="article-148895.r15">[15]</xref></p>
        <p>For individuals who develop end-stage renal disease (ESRD), options such as dialysis and renal transplantation are provided. While there is evidence of disease recurrence in renal allografts, it is important to note that acceptable long-term outcomes have been observed in transplant patients.</p>
        <p>Looking towards the future, a potential therapeutic avenue involves recombinant human LCAT gene and enzyme replacement. In&#x000a0;1 study, the infusion of recombinant human LCAT enzyme exhibited improvements in anemia and renal function. Moreover, it led to transient normalization of lipid abnormalities.<xref ref-type="bibr" rid="article-148895.r16">[16]</xref></p>
      </sec>
      <sec id="article-148895.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The conditions to consider in the differential diagnosis of LCAT deficiency include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Familial hypercholesterolemia: an autosomal dominant condition resulting in elevated LDL-C levels causing premature cardiovascular disease&#x000a0;<xref ref-type="bibr" rid="article-148895.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Tangier Disease: autosomal recessive disorder and&#x000a0;autosomal co-dominant patterns characterized by severe deficiency of HDL resulting in hyperplastic yellow or orange coloration of the tonsils, hepatosplenomegaly, and peripheral neuropathy&#x000a0;<xref ref-type="bibr" rid="article-148895.r18">[18]</xref>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Niemann-Pick disease: an autosomal recessive lysosomal disorder characterized by accumulation of byproducts that leads to hepatosplenomegaly and cherry red spots&#x000a0;<xref ref-type="bibr" rid="article-148895.r19">[19]</xref>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypertriglyceridemia: dyslipidemia due to elevated triglyceride levels resulting in acute pancreatitis, cardiovascular disease, and palmar xanthomas</p>
          </list-item>
          <list-item>
            <p>Familial HDL deficiency: an autosomal dominant disorder with low HDL and risk of premature cardiovascular events. The features of LCAT deficiency relating to corneal opacification and renal dysfunction typically are not present.<xref ref-type="bibr" rid="article-148895.r20">[20]</xref>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Abetalipoproteinemia: rare autosomal recessive disorder resulting in low or absent cholesterol, LDL, and VLDL levels. Clinical features of this disease are red blood cell acanthocytes, fat malabsorption, spinocerebellar degeneration, and retinitis pigmentosa.<xref ref-type="bibr" rid="article-148895.r21">[21]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-148895.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of LCAT deficiency hinges on the severity of the mutation. Complete LCAT deficiency manifests as a more severe disease that appears early in childhood, accompanied by pronounced symptoms. In contrast, partial LCAT deficiency with milder symptoms typically emerges later in life. Due to the condition's rarity, there is currently limited data on mortality rates.</p>
      </sec>
      <sec id="article-148895.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The complications of LCAT deficiency vary depending on the subtype. In cases of complete LCAT deficiency, individuals often experience proteinuria, which indicates renal dysfunction.<xref ref-type="bibr" rid="article-148895.r22">[22]</xref><xref ref-type="bibr" rid="article-148895.r23">[23]</xref>&#x000a0;This can eventually progress to renal failure, necessitating interventions like dialysis or a renal transplant.</p>
        <p>On the other hand, those with partial LCAT deficiency commonly develop corneal opacification. This occurs due to the accumulation of cholesterol in the eyes, leading to significant visual impairment.</p>
        <p>Both types of LCAT deficiency result in dyslipidemia due to the disruption of the regulatory role of HDL &#x000a0;in cholesterol transport. This disruption heightens the risk of atherosclerosis, which, in turn, increases the susceptibility to cardiovascular events such as myocardial infarction and stroke.</p>
      </sec>
      <sec id="article-148895.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Due to the intricate nature of this disease, an interdisciplinary approach is required for its optimal management. The consultations holding significant importance are the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Endocrinologists and nutritionists can offer valuable insights into the diagnosis and dietary considerations.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Ophthalmologists play a crucial role in monitoring visual impairment and other eye-related complications. In some cases, more extensive interventions like a corneal transplant might be necessary.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Nephrologists are particularly valuable if renal impairment arises, as this could potentially necessitate dialysis.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Genetic counseling focuses discussions on the mode of inheritance, clinical manifestations, and potential complications.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-148895.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>HDL, also known as good cholesterol, is crucial in preventing significant cardiovascular events like heart attacks and strokes by extracting cholesterol from peripheral tissues and conveying it to the liver for metabolism. Moreover, HDL possesses unique attributes, including anti-inflammatory properties, endothelial function enhancement, and thrombus formation prevention.</p>
        <p>Maintaining a healthy lifestyle is imperative through regular aerobic exercise, a balanced and nutritious diet, and smoking cessation. Specific dietary recommendations are advised for individuals with a heightened cardiovascular risk. Meals enriched with omega-3 fatty acids are particularly beneficial in such cases. A prime example of such a diet is the Mediterranean diet, characterized by its plant-based nature and abundance of healthy fats.</p>
      </sec>
      <sec id="article-148895.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Managing LCAT deficiency requires a comprehensive, multidisciplinary approach involving experts from various fields, including endocrinology, nephrology, ophthalmology, and nutrition. Each specialist is pivotal in identifying complications and reducing the associated mortality and morbidity. This rare condition affects only a few individuals, so genetic counseling should be available following diagnosis. This counseling&#x000a0;should cover essential topics such as the mode of inheritance, clinical manifestations, and potential complications. For individuals considering having children, prenatal testing can offer valuable insights.</p>
        <p>Due to the rarity of this disease, there are currently no available randomized controlled trials. However, there is promising potential for therapy utilizing recombinant human LCAT enzyme, which has demonstrated beneficial effects.<xref ref-type="bibr" rid="article-148895.r24">[24]</xref>&#x000a0;Presently, the mainstay of management involves lifestyle adjustments and the use of antihypertensive medications, both of which have shown promise in slowing the progression of the disease.</p>
      </sec>
      <sec id="article-148895.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=148895&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=148895">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/lecithin-cholesterol-acyltransferase-deficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=148895">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/148895/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=148895">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-148895.s16">
        <title>References</title>
        <ref id="article-148895.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Clemens</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Hereditary lecithin-cholesterol acyltransferase deficiency. Case report of a German patient.</article-title>
            <source>Am J Clin Pathol</source>
            <year>1987</year>
            <month>Oct</month>
            <volume>88</volume>
            <issue>4</issue>
            <fpage>510</fpage>
            <page-range>510-6</page-range>
            <pub-id pub-id-type="pmid">3661502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santamarina-Fojo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hoeg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Brewer</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.</article-title>
            <source>Curr Opin Lipidol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-75</page-range>
            <pub-id pub-id-type="pmid">10882342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>El&#x000ed;as-L&#x000f3;pez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Martag&#x000f3;n</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-M&#x000e9;ndez</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>MLO</given-names>
              </name>
              <name>
                <surname>Segura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tusi&#x000e9;</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Aguilar-Salinas</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred.</article-title>
            <source>Lipids Health Dis</source>
            <year>2021</year>
            <month>Jul</month>
            <day>13</day>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <pub-id pub-id-type="pmid">34256778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leal-Gonzalez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ramos-Reyes</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Moncada-Madrazo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Apodaca-Ramos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Morales-Palomino</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Vald&#x000e9;s-Cepeda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marrufo-Garc&#x000ed;a</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Rangel-Nava</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>LCAT deficiency and pregnancy: Case report.</article-title>
            <source>Obstet Med</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>193</fpage>
            <page-range>193-196</page-range>
            <pub-id pub-id-type="pmid">34646351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ginsberg</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>Lipoprotein physiology.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>503</fpage>
            <page-range>503-19</page-range>
            <pub-id pub-id-type="pmid">9785050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandhofer</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>[Physiology and pathophysiology of the metabolism of lipoproteins].</article-title>
            <source>Wien Med Wochenschr</source>
            <year>1994</year>
            <volume>144</volume>
            <issue>12-13</issue>
            <fpage>286</fpage>
            <page-range>286-90</page-range>
            <pub-id pub-id-type="pmid">8650930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tosheska Trajkovska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Topuzovska</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol.</article-title>
            <source>Anatol J Cardiol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-154</page-range>
            <pub-id pub-id-type="pmid">28766509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuroda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bujo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yokote</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Murano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ogura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ikewaki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koseki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takeuchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakatsuka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matsuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yokoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Harada-Shiba</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Current Status of Familial LCAT Deficiency in Japan.</article-title>
            <source>J Atheroscler Thromb</source>
            <year>2021</year>
            <month>Jul</month>
            <day>01</day>
            <volume>28</volume>
            <issue>7</issue>
            <fpage>679</fpage>
            <page-range>679-691</page-range>
            <pub-id pub-id-type="pmid">33867422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naghashpour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cualing</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Splenomegaly with sea-blue histiocytosis, dyslipidemia, and nephropathy in a patient with lecithin-cholesterol acyltransferase deficiency: a clinicopathologic correlation.</article-title>
            <source>Metabolism</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>58</volume>
            <issue>10</issue>
            <fpage>1459</fpage>
            <page-range>1459-64</page-range>
            <pub-id pub-id-type="pmid">19592052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castro-Ferreira</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Carmo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Corr&#x000ea;a</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sampaio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pedro</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Pra&#x000e7;a</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers.</article-title>
            <source>JIMD Rep</source>
            <year>2018</year>
            <volume>40</volume>
            <fpage>55</fpage>
            <page-range>55-62</page-range>
            <pub-id pub-id-type="pmid">28983876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balwani</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ghodela</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Kute</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Gera</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Vanikar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trivedi</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>An unusual presentation of LCAT deficiency as nephrotic syndrome with normal serum HDL-C level.</article-title>
            <source>J Nephropharmacol</source>
            <year>2017</year>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-26</page-range>
            <pub-id pub-id-type="pmid">28508023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Masuda</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Koseki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical features and visual function in a patient with Fish-eye disease: Quantitative measurements and optical coherence tomography.</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>10</volume>
            <fpage>137</fpage>
            <page-range>137-141</page-range>
            <pub-id pub-id-type="pmid">29687088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Althaf</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Almana</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abdelfadiel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amer</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Al-Hussain</surname>
                <given-names>TO</given-names>
              </name>
            </person-group>
            <article-title>Familial lecithin-cholesterol acyltransferase (LCAT) deficiency; a differential of proteinuria.</article-title>
            <source>J Nephropathol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-8</page-range>
            <pub-id pub-id-type="pmid">25657982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oldoni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baldassarre</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Castelnuovo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ossoli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Capelleveen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hovingh</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>De Groot</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bochem</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simonelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barbieri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Veglia</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Franceschini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kuivenhoven</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Holleboom</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Calabresi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.</article-title>
            <source>Circulation</source>
            <year>2018</year>
            <month>Sep</month>
            <day>04</day>
            <volume>138</volume>
            <issue>10</issue>
            <fpage>1000</fpage>
            <page-range>1000-1007</page-range>
            <pub-id pub-id-type="pmid">29748187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miarka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Idzior-Walu&#x0015b;</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ku&#x0017a;niewski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walu&#x0015b;-Miarka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Klupa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Su&#x00142;owicz</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency.</article-title>
            <source>Clin Exp Nephrol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>424</fpage>
            <page-range>424-429</page-range>
            <pub-id pub-id-type="pmid">21327698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>LCAT- targeted therapies: Progress, failures and future.</article-title>
            <source>Biomed Pharmacother</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>147</volume>
            <fpage>112677</fpage>
            <pub-id pub-id-type="pmid">35121343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ison</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Knowles</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <chapter-title>Familial Hypercholesterolemia</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2014</year>
            <month>1</month>
            <day>2</day>
            <pub-id pub-id-type="pmid">24404629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Burnett</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hooper</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>SPA</given-names>
              </name>
              <name>
                <surname>Hegele</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <chapter-title>Tangier Disease</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2019</year>
            <month>11</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">31751110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r19">
          <label>19</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bajwa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Azhar</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <chapter-title>Niemann-Pick Disease</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>3</month>
            <day>6</day>
            <pub-id pub-id-type="pmid">32310589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marcil</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boucher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Krimbou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Solymoss</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Davignon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frohlich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Genest</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.</article-title>
            <source>Arterioscler Thromb Vasc Biol</source>
            <year>1995</year>
            <month>Aug</month>
            <volume>15</volume>
            <issue>8</issue>
            <fpage>1015</fpage>
            <page-range>1015-24</page-range>
            <pub-id pub-id-type="pmid">7627690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r21">
          <label>21</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Junaid</surname>
                <given-names>SZS</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Abetalipoproteinemia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>31</day>
            <pub-id pub-id-type="pmid">30020727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moradi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pahl</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Elahimehr</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vaziri</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.</article-title>
            <source>Transl Res</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>153</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-85</page-range>
            <pub-id pub-id-type="pmid">19138652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaziri</surname>
                <given-names>ND</given-names>
              </name>
            </person-group>
            <article-title>Causes of dysregulation of lipid metabolism in chronic renal failure.</article-title>
            <source>Semin Dial</source>
            <year>2009</year>
            <season>Nov-Dec</season>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>644</fpage>
            <page-range>644-51</page-range>
            <pub-id pub-id-type="pmid">20017835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-148895.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuroda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maezawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kubota</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mitsukawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shiko</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ozawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawasaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hanaoka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yokote</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>LCAT-trial-24 weeks: Protocol for a clinical study to evaluate the safety of regenerative medicine and gene therapy by the autologous transplantation of human lecithin:cholesterol acyltransferase gene-transduced human pre-adipocytes.</article-title>
            <source>Contemp Clin Trials Commun</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>28</volume>
            <fpage>100946</fpage>
            <pub-id pub-id-type="pmid">35734220</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
